The Pennsylvania Department of Drug and Alcohol Programs (DDAP) is awarding $9 million to single county authorities (SCAs) to establish or expand crisis stabilization services for individuals who present with substance use disorder (SUD) and co-occurring mental health symptoms. Such services include assessment and stabilization of acute physical and psychiatric symptoms, which may include medical management and behavioral interventions, induction on medication-assisted treatment, level of care assessments, short-term stays, and connections to supportive services.

Grants of up to $3 million will be awarded to eligible SCAs and can be applied toward a range of activities, including construction and building infrastructure, staffing, and programming. The SCAs may provide or coordinate the services.

SUD crisis stabilization services must have the capacity to recognize and manage individuals presenting with a wide range of SUD-related symptoms, mental health disorders, and developmental disabilities. Funds can be applied toward a range of activities, including construction and building infrastructure, staffing, and evidence-based programming.

Earlier this year, the General Assembly allocated its 2022 $17 million portion of Pennsylvania’s $1.07 billion opioid settlement to DDAP. The overall settlement was reached between states’ attorneys general and Johnson & Johnson, AmerisourceBergen, Cardinal Health, and McKesson.

DDAP plans to use the remaining money from this year’s opioid settlement allocation to provide treatment and recovery support services to communities of color; address workforce issues; and fund services in the Kensington area of Philadelphia with a $1 million grant. Read more about the crisis services grants.